12.08
+2.72%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Neogen
From its filings with the US Securities and Exchange Commission
Neogen is based in Lansing, Michigan and is incorporated in Michigan. Its shares trade on Nasdaq under the ticker NEOG. The SEC classifies its business as in vitro & in vivo diagnostic substances. In the fiscal year to 31 May 2026, it reported revenue of $870.4m and a net loss of $7.9m. At that date it held total assets of $3.35bn and shareholders' equity of $2.09bn.
Neogen Corporation and its subsidiaries develop, manufacture and market a diverse line of products and services dedicated to food and animal safety. Our Food Safety segment consists primarily of diagnostic test kits and complementary products (e.g., culture media) sold to food and animal feed producers and processors to preserve the safety and quality of food to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. These products also ensure the general hygiene of the food manufacturing environment. We also have products to determine food quality and nutritional components. The majority of the test kits are consumables, single-use culture, immunoassay and nucleic acid detection products that rely on proprietary antibodies and RNA and DNA testing methodologies to produce rapid and accurate test results. Our line of food safety services also includes advanced software systems that help testers objectively analyze, store and identify emerging issues from their results from multiple locations over extended periods.
Quoted from its 10-K, filed 30 Jul 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 23 Aug 1989
- Employees
- 2,636
- Website
- neogen.com ↗
- Head office
- 620 LESHER PLACE, LANSING, MI, 48912
- Incorporated in
- MI
- Classification
- In Vitro & In Vivo Diagnostic Substances
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. James BorelIndependent Chairman of the Board$292,500
- Mr. Mikhael NassifPresident, Chief Executive Officer
- Mr. David NaemuraChief Financial Officer, Chief Operating Officer$2.7m
- Dr. Amy RocklinChief Legal & Compliance Officer$1.8m
- Mr. Thierry BernardIndependent Director$226,467
- Dr. William BoehmIndependent Director$247,500
- Mr. Jeffrey CapelloIndependent Director$237,500
- Dr. Ronald GreenIndependent Director$242,500
- Ms. Aashima GuptaIndependent Director$235,000
- Mr. Raphael RodriguezIndependent Director$235,000
- Ms. Andrea WainerIndependent Director
- Dr. Catherine WotekiIndependent Director$242,500
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 35
- Environment
- 9
- Social
- 42
- Governance
- 55
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Neogen Corp boasts several key strengths that contribute to its success in the market. Firstly, the company has a strong reputation for producing high-quality and innovative products. This reputation has been built through years of commitment to research and development, resulting in cutting-edge solutions for its customers.
- Secondly, Neogen Corp has a diverse product portfolio, spanning multiple industries such as food safety, animal health, and genomics. This diversification mitigates risks associated with relying solely on one market segment and allows Neogen Corp to tap into various revenue streams.
- Additionally, the company has a global presence, with operations in multiple countries. This international footprint provides Neogen Corp with access to a broader customer base and market opportunities worldwide.
Weaknesses
- Despite its strengths, Neogen Corp also faces certain weaknesses that need to be addressed. One prominent weakness is its heavy dependence on key customers. If a major customer were to reduce its purchases or switch to a competitor, Neogen Corp could experience a significant decline in sales.
- Furthermore, Neogen Corp has limited manufacturing capabilities, relying on third-party manufacturers for a portion of its products. This dependence on external vendors introduces potential risks and could impact product availability and quality control.
Opportunities
- Neogen Corp can leverage various opportunities to drive growth and expand its market reach. For instance, increasing consumer demand for food safety solutions presents a chance for the company to introduce new products or enhance existing offerings. This trend aligns with Neogen Corp's expertise, giving it a competitive advantage.
- Additionally, the growing adoption of genomics and molecular diagnostics provides Neogen Corp with an opportunity to further penetrate the healthcare industry. By investing in research and partnerships, the company can develop advanced genetic testing and diagnostic solutions to meet the evolving needs of the market.
Threats
- Neogen Corp faces several threats that could impact its performance and market position. One significant threat is intense competition within its target markets. Competitors may launch similar products or offer competitive pricing, potentially eroding Neogen Corp's market share.
- Additionally, regulatory changes and stricter industry standards pose a threat to Neogen Corp's operations. Compliance with evolving regulations requires continuous adaptation and investment in research and development, which may strain the company's resources.
- Lastly, economic downturns and fluctuations in exchange rates can negatively affect Neogen Corp's financial performance, particularly in international markets where currency volatility is a concern.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.